|
RGPD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.40479999999277E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.622900E-04 |
| Normal-vs-Stage2 |
9.830900E-04 |
| Normal-vs-Stage3 |
1.762550E-04 |
| Normal-vs-Stage4 |
1.357500E-04 |
| Stage1-vs-Stage2 |
4.253800E-01 |
| Stage1-vs-Stage3 |
3.486000E-01 |
| Stage1-vs-Stage4 |
2.002000E-01 |
| Stage2-vs-Stage3 |
9.286800E-01 |
| Stage2-vs-Stage4 |
7.371200E-01 |
| Stage3-vs-Stage4 |
6.239000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.650299999997E-05 |
| Normal-vs-AfricanAmerican |
1.701750E-02 |
| Normal-vs-Asian |
6.502100E-03 |
| Caucasian-vs-AfricanAmerican |
8.988800E-01 |
| Caucasian-vs-Asian |
5.147200E-01 |
| AfricanAmerican-vs-Asian |
7.427600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.697730E-03 |
| Normal-vs-Female |
4.04310000000629E-05 |
| Male-vs-Female |
4.050000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.198220E-03 |
| Normal-vs-Age(41-60Yrs) |
2.038200E-04 |
| Normal-vs-Age(61-80Yrs) |
7.72510000000004E-05 |
| Normal-vs-Age(81-100Yrs) |
6.682400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.093800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.351600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.547400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.916200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.775800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.363200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.501900E-03 |
| Classical-VS-Follicular |
6.986300E-02 |
| Classical-VS-Other |
8.630400E-01 |
| Classical-VS-Normal |
1.395110E-03 |
| Tall-VS-Follicular |
3.304400E-01 |
| Tall-VS-Other |
3.481800E-01 |
| Tall-VS-Normal |
1.65699999999935E-05 |
| Follicular-VS-Other |
4.836600E-01 |
| Follicular-VS-Normal |
2.408800E-04 |
| Other-VS-Normal |
2.851800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67330000000665E-05 |
| Normal-vs-N1 |
6.278300E-03 |
| N0-vs-N1 |
5.345600E-01 |
|
|
